Article Information
vol. 7 no. 2
Published By
Online ISSN
History
- Received December 14, 2020
- Accepted January 29, 2021
- Published online May 31, 2021.
Article Versions
- previous version (February 18, 2021 - 10:46).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Muhammad Rehan Sarwar1,
- Vanessa Marie McDonald2,3,4,
- Michael John Abramson5,
- Eldho Paul5 and
- Johnson George1⇑
- 1Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia
- 2National Health and Medical Research Council Centre for Research Excellence in Severe Asthma and Centre of Excellence in Treatable Traits, The University of Newcastle, Callaghan, Australia
- 3The Priority Research Centre for Healthy Lungs, School of Nursing and Midwifery, Callaghan, Australia
- 4Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, Newcastle, Australia
- 5School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
- Johnson George, Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia. E-mail: johnson.george{at}monash.edu
Article usage
Altmetrics
Vol 7 Issue 2
Table of Contents
Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD
